U.S. Pharma Stock News

NYSE:DELL
NYSE:DELLTech

Dell Technologies (DELL) Margin Improvement Challenges Cautious Narratives In FY 2026 Earnings

Dell Technologies FY 2026 earnings snapshot Dell Technologies (DELL) just closed FY 2026 with fourth quarter revenue of US$33.4b and basic EPS of US$3.37, rounding out a year where trailing twelve month revenue reached US$113.5b and EPS came in at US$8.68. Over recent quarters the company has seen quarterly revenue move from US$23.4b in Q1 FY 2026 to US$33.4b in Q4, while basic EPS has ranged from US$1.39 to US$3.37 across the same period. This sets up a story that hinges on how efficiently...
NasdaqGS:ATAT
NasdaqGS:ATATHospitality

Atour Lifestyle Holdings (NasdaqGS:ATAT) Margin Slippage Tests Bullish Earnings Growth Narrative

Atour Lifestyle Holdings (NasdaqGS:ATAT) FY 2025 earnings snapshot Atour Lifestyle Holdings (NasdaqGS:ATAT) has put fresh numbers on the board for FY 2025, with third quarter revenue of C¥2,627.97 million and basic EPS of C¥3.41 anchoring a trailing twelve month EPS of C¥10.62 on revenue of C¥9,086.34 million. The company has seen revenue move from C¥6,669.14 million and trailing EPS of C¥8.46 in the third quarter of 2024 to C¥9,086.34 million and C¥10.62 in the third quarter of 2025, giving...
NasdaqCM:GOAI
NasdaqCM:GOAIMedia

Eva Live (GOAI) Profitability Turnaround Challenges Bearish Narratives After FY 2025 Results

Eva Live (NasdaqCM:GOAI) posts FY 2025 results and confirms profitability Eva Live (NasdaqCM:GOAI) has reported its FY 2025 results with third quarter revenue of US$4.9 million and basic EPS of US$0.06, while trailing twelve month revenue came in at US$15.7 million and basic EPS at US$0.25 as the business remained profitable over the period. The company has seen revenue move from US$2.9 million in Q4 2024 to US$4.9 million in Q3 2025, with basic EPS shifting from US$0.06 in Q4 2024 to US$0.06...
NasdaqCM:CHCI
NasdaqCM:CHCIReal Estate

Comstock Holding Companies (CHCI) Margin Strength Tests Bullish Narratives After EPS Slows

Comstock Holding Companies (CHCI) just posted its FY 2025 third quarter numbers, with revenue of US$13.3 million and basic EPS of US$0.05, set against trailing twelve month revenue of US$55.8 million and EPS of US$1.39 that reflects earnings growth of 127.8% over the past year. Over the last few quarters, revenue has tracked between US$10.8 million and US$16.9 million, while quarterly EPS has moved from US$0.05 to US$1.04. This gives investors a clear view of how profitability has translated...
NYSE:TDS
NYSE:TDSWireless Telecom

Kerrisdale Stake And Leadership Change Reframe Telephone And Data Systems

Kerrisdale Advisers has taken a new position in Telephone and Data Systems (NYSE:TDS) as the company shifts its focus toward fiber broadband and infrastructure. TDS has been reshaping its portfolio, including divestitures in its wireless segment, as part of this business repositioning. The company has also announced the upcoming retirement of a senior executive responsible for strategy and corporate development. For you as an investor, NYSE:TDS now sits at the intersection of telecom...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) Posts Q4 EPS Loss That Tests Bullish Earnings Rebound Narrative

Semtech (SMTC) has wrapped up FY 2026 with fourth quarter revenue of US$274.4 million, a basic EPS loss of US$0.32, and net income excluding extra items showing a loss of US$29.8 million, keeping profitability in focus for investors. Over the past six quarters, the company has seen revenue move from US$236.8 million in FY 2025 Q3 to US$274.4 million in FY 2026 Q4, while quarterly basic EPS has swung between a profit of US$0.48 and a loss of US$0.32, creating a mixed backdrop for margins. With...
NYSE:BKKT
NYSE:BKKTCapital Markets

Bakkt (BKKT) Returns To EPS Loss In Q3 2025 Challenging Profitability Narrative

Bakkt (BKKT) just posted its FY 2025 results with third quarter revenue of US$402.2 million and a basic EPS loss of US$1.02, while trailing twelve month revenue sat at US$3.9 billion against a basic EPS loss of US$5.06. Over recent periods, revenue has ranged from US$214.5 million in Q4 2023 to US$1.8 billion in Q4 2024 and US$1.1 billion in Q1 2025, with EPS swinging between a loss of US$7.25 in Q4 2023 and a profit of US$1.18 in Q1 2025. This gives investors a mixed picture on earnings...
NasdaqGS:KLTR
NasdaqGS:KLTRSoftware

Kaltura (KLTR) Losses Narrow Again In Q3 FY 2025 Challenging Bearish Profitability Concerns

Kaltura FY 2025 earnings snapshot Kaltura (KLTR) has just posted its FY 2025 third quarter numbers, reporting revenue of US$43.9 million and a basic EPS loss of US$0.02, alongside net income excluding extra items of a US$2.6 million loss. The company’s recent quarterly revenue has moved from US$45.6 million in Q4 2024 to US$44.5 million in Q2 2025 and US$43.9 million in Q3 2025. Over the same period, basic EPS has ranged between a loss of US$0.07 and a loss of US$0.02. The latest figures...
NYSE:EMN
NYSE:EMNChemicals

Does Eastman’s Cost Cuts And Kingsport Upside Change The Bull Case For EMN?

In its latest quarterly update, Eastman Chemical reported earnings per share above expectations but slightly missed on revenue, highlighted US$60 million of incremental 2025 earnings from its Kingsport methanolysis facility, raised its dividend for the 16th consecutive year, and returned about US$500 million via dividends and buybacks. The company also lifted its 2026 cost reduction target to US$125 million–US$150 million and withheld full-year EPS guidance, underscoring both internal...
NasdaqCM:AGEN
NasdaqCM:AGENBiotechs

Agenus (AGEN) Q3 Profit Of US$63.9 Million Tests Longstanding Loss-Making Narrative

Agenus (NasdaqCM:AGEN) has swung to a profit in Q3 FY 2025, reporting total revenue of US$30.2 million and EPS of US$2.00, with net income of US$63.9 million for the period. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 to US$26.8 million in Q4 2024 and then to US$30.2 million in Q3 2025, while EPS shifted from a loss of US$2.52 per share in Q2 2024 to a loss of US$2.00 in Q4 2024 and then to a profit of US$2.00 in Q3 2025, indicating a sharp turn in reported...
NYSE:AVD
NYSE:AVDChemicals

American Vanguard (AVD) Quarterly Loss Deepens Margin Concerns And Challenges Profitability Narrative

American Vanguard (AVD) opened FY 2025 with mixed results, reporting Q3 revenue of US$119.3 million and a basic EPS loss of US$0.43, while on a trailing twelve month basis revenue stood at US$530.1 million alongside a basic EPS loss of US$3.96. The company has seen quarterly revenue move between US$115.8 million and US$165.6 million over the past six reported quarters, with basic EPS losses ranging from US$0.03 to US$3.21. This highlights pressure on profitability even as the top line remains...
NYSE:FF
NYSE:FFOil and Gas

FutureFuel (FF) Q3 Loss Deepens Five Year Earnings Deterioration Narrative

FutureFuel (FF) opened FY 2025 with a tough third quarter, reporting revenue of US$22.7 million and a basic EPS loss of US$0.21 alongside a net loss of US$9.3 million, while the trailing twelve months show revenue of US$137.4 million and a basic EPS loss of US$0.79 tied to a net loss of US$34.6 million. Over recent quarters, the company has seen revenue move from US$72.4 million with EPS of US$0.22 in Q2 2024 to US$35.7 million with an EPS loss of US$0.24 in Q2 2025 and then to US$22.7...
NYSEAM:AREN
NYSEAM:ARENInteractive Media and Services

Arena Group Holdings (AREN) Posts US$6.9m Q3 Profit Testing Bullish Profitability Narrative

Arena Group Holdings (AREN) has just posted its FY 2025 third quarter numbers, with revenue of US$29.8 million and basic EPS of US$0.14, while trailing twelve month revenue came in at US$142.8 million and EPS at US$0.64. Over recent quarters the company has seen revenue move between US$27.2 million and US$45.0 million per period, with basic EPS ranging from a loss of US$0.24 to a profit of US$0.26, and trailing twelve month net income excluding extra items reaching US$30.5 million. For...
NasdaqCM:HFFG
NasdaqCM:HFFGConsumer Retailing

HF Foods Group (HFFG) Earnings Slip Back To Loss Challenges Profitability Turnaround Narrative

HF Foods Group (HFFG) has just posted its FY 2025 third quarter numbers, with revenue at US$307 million and a basic EPS loss of US$0.02, while on a trailing 12 month basis revenue sits at about US$1.23 billion and basic EPS at a loss of US$0.86. The company has seen quarterly revenue move from US$302 million in Q2 FY 2024 to US$307 million in Q3 FY 2025, with basic EPS shifting across that period from roughly breakeven at US$0.00 in Q2 FY 2024 to a loss of US$0.02 in the latest quarter...
NasdaqGS:TRST
NasdaqGS:TRSTBanks

TrustCo Bank Corp NY (TRST) Net Margin Improvement Reinforces Bullish Narratives

TrustCo Bank Corp NY (TRST) has rounded out FY 2025 with fourth quarter revenue of US$47.8 million and basic EPS of US$0.85, backed by trailing twelve month revenue of US$186.3 million and EPS of US$3.26. Over the past year, revenue has moved from US$169.8 million to US$186.3 million on a trailing basis, while basic EPS has shifted from US$2.57 to US$3.26. This sets the scene for investors to focus on how net profit margins at 32.8% and recent earnings growth shape the quality of this...
NYSE:HUYA
NYSE:HUYAEntertainment

Huya (NYSE:HUYA) Swings Back To Q3 EPS Profit Challenging Ongoing Loss Concerns

HUYA (NYSE:HUYA) has posted its latest FY 2025 numbers with Q3 revenue of C¥1.7b and basic EPS of C¥0.04, giving investors an opportunity to reassess the streaming platform's earnings path. The company reported revenue of C¥1.5b in Q1 2025, C¥1.6b in Q2 2025, and C¥1.7b in Q3 2025, while basic EPS moved from C¥0.00 in Q1 to a loss of C¥0.02 in Q2 before returning to a profit of C¥0.04 in Q3. This presents a mixed picture on margins but offers a clearer view of where profitability pressure...
NasdaqCM:MVST
NasdaqCM:MVSTMachinery

Microvast Holdings (MVST) Breakeven EPS In Q3 2025 Tests Profitability Narratives

Microvast Holdings (MVST) has posted its latest FY 2025 numbers with Q3 revenue at US$123.3 million, basic EPS at a loss of US$0.00 per share, and net income at a loss of US$1.5 million, while the trailing twelve months show revenue of US$444.5 million and a loss per share of US$0.40. The company has seen quarterly revenue range from US$83.7 million to US$123.3 million over the last six reported periods. Over the same period, basic EPS has swung between a profit of US$0.19 and losses of up to...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Is It Too Late To Consider Golar LNG (GLNG) After Its Strong Multi Year Share Price Run?

Investors wondering if Golar LNG is still reasonably priced after a strong run, or if the easy gains are already behind it, can use this article to focus on what the current share price indicates about value. The stock recently closed at US$44.86, with returns of 3.3% over 30 days, 18.2% year to date and 31.0% over the last year. The past 3 years and 5 years show very large gains of 142.3% and 326.6% respectively. Recent coverage has centered on how Golar LNG is positioned within the energy...
NYSE:HHH
NYSE:HHHReal Estate

Do Diverging Moves Around Earnings Reveal a Turning Point in Howard Hughes' (HHH) Governance Story?

Recent filings show Concorde Financial Corp fully exited its position in Howard Hughes Holdings by selling 52,047 shares, while General Counsel Joseph Valane bought 1,260 shares shortly after the company posted fourth-quarter 2025 results with lower-than-expected EPS but higher-than-expected revenue of US$624.4 million. These opposing moves by an institutional investor and a senior insider come as Howard Hughes pursues a holding-company pivot, faces leverage concerns, and attracts growing...
NasdaqGS:BMRN
NasdaqGS:BMRNBiotechs

A Look At BioMarin Pharmaceutical (BMRN) Valuation After A Year Of Softer Share Price Momentum

BioMarin Pharmaceutical (BMRN) is back on investor watch after recent trading left the shares about 20% lower over the past year, despite annual revenue of US$3.2b and net income of US$348.9m. See our latest analysis for BioMarin Pharmaceutical. The recent 1 day share price return of 1.85% decline and 7 day share price return of 5.67% decline sit against a 90 day share price return of 10.93% and a 1 year total shareholder return of 19.73% decline, suggesting short term momentum has softened...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

What Strategic Education (STRA)'s Analyst Upgrades and Earnings Revisions Mean For Shareholders

In recent weeks, analysts have raised their earnings forecasts for Strategic Education and upgraded the stock to a Zacks Rank #1 (Strong Buy), signaling higher confidence in its expected financial performance. This broad-based improvement in earnings estimates suggests that analysts are reassessing the company’s underlying business trends rather than reacting to a single, one-off development. We’ll now examine how this stronger analyst earnings outlook may reshape Strategic Education’s...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

EyePoint (EYPT) Is Down 14.2% After Weak Q4 Results And DURAVYU Optimism - What's Changed

EyePoint Pharmaceuticals reported fourth-quarter 2025 revenue of US$620,000 versus US$11.59 million a year earlier, with net loss widening to US$67.61 million and basic loss per share from continuing operations rising to US$0.81, while also granting long-term stock options and ending 2025 with cash reportedly sufficient to fund operations into late 2027. Despite weaker financial results, investor attention has shifted toward the CEO’s recent purchase of 1,500 shares, analyst optimism linked...
NasdaqGM:QCRH
NasdaqGM:QCRHBanks

Is It Time To Reassess QCR Holdings (QCRH) After Recent Share Price Weakness?

Wondering if QCR Holdings at around US$82.64 is offering value or asking too much at today's price? This breakdown will help you see what the current market is really pricing in. The stock has seen a 0.9% decline over the last 7 days and a 10.5% decline over the last 30 days, while returns sit at 0.6% year to date and 11.6% over the past year. This gives you a mixed set of signals to weigh. Recent news coverage has focused on QCR Holdings as a regional banking name that investors continue to...
NasdaqGM:PAYO
NasdaqGM:PAYODiversified Financial

Payoneer ESOP Shelf Filing Raises Fresh Questions On Dilution And Growth

Payoneer Global (NasdaqGM:PAYO) has filed a shelf registration statement for a potential US$79 million offering tied to its Employee Stock Ownership Plan. The filing sets up the ability to issue or sell shares in connection with the ESOP over time, affecting how employee equity is managed. This move adds a fresh element to the Payoneer equity story beyond the recent focus on partnerships and valuation discussion. Payoneer operates a global payments and financial services platform that...